Torlińska T, Grzymisławski M, Paluszak J, Sosnowski P, Torliński L, Koźlik J
Department of Physiology, School of Medicine, Poznań.
Acta Physiol Pol. 1987 Jul-Aug;38(4):353-60.
Short (7 days) T3-treatment has no influence on the plasma glucose and FFA concentration and blood lactate level, as well as on the hepatic glycogen content in the rats. The rise in T3 levels, observed in our study, was accompanied by a fall in T4 concentrations, indicating suppression of the endogenous T4 production. On the other hand, glycogenolytic activity of rat serum in vitro is the highest in the system: control liver slices-serum of rats pretreated with T3 as compared to the system: control liver slices-control serum. These observations may lead to conclusions, that serum of rats pretreated with T3 contains factors exhibiting the greater ability to mobilize glucose from liver slices than the control serum (euthyroid). The possibility, that pretreatment with T3 may cause a decrease in the number and/or affinity of beta-adrenergic receptors in the rat liver, is discussed.
短期(7天)T3治疗对大鼠的血浆葡萄糖、游离脂肪酸(FFA)浓度、血乳酸水平以及肝糖原含量均无影响。在我们的研究中观察到,T3水平升高的同时T4浓度下降,这表明内源性T4生成受到抑制。另一方面,体外大鼠血清的糖原分解活性在以下系统中最高:对照肝切片 - 经T3预处理的大鼠血清,与以下系统相比:对照肝切片 - 对照血清。这些观察结果可能得出以下结论:经T3预处理的大鼠血清中所含的因子比对照血清(甲状腺功能正常)具有更强的从肝切片中动员葡萄糖的能力。文中还讨论了T3预处理可能导致大鼠肝脏中β - 肾上腺素能受体数量和/或亲和力降低的可能性。